Saturday, November 7, 2026
The top medical stories of the day, as they ran.
Morning edition
14 stories
- 1Novartis reports nine tumor cases in children treated with ZolgensmaDrug safety · 3 outlets
- 2FDA approves Rybrevant Faspro for recurrent or metastatic head and neck cancerDrugs and FDA · 4 outlets
- 3PAHO to review U.S. measles elimination status amid rising casesOutbreaks · 3 outlets
- 4Former health adviser accuses White House officials of favoring industryHealth policy · 4 outlets
- 5Trump administration shifts global health aid to country-by-country agreementsGlobal health · 2 outlets
- 6Doctors warn of small breast cancer risk with menopause hormone therapyDrugs and FDA · 2 outlets
- 7Study finds many infants thought to have peanut allergy are not allergicResearch · 2 outlets
- 8Health ISAC warns hospitals after cyberattack on French blood servicePublic health · 2 outlets
- 9Hims & Hers will offer Eli Lilly’s branded obesity drugsDrugs and FDA · 2 outlets
- 10FDA urges DPD deficiency discussions before capecitabine or fluorouracil treatmentDrugs and FDA · 1 outlet
- 11FDA approves gemcitabine intravesical system for certain bladder cancer patientsDrugs and FDA · 1 outlet
- 12FDA approves niraparib combination for BRCA2-mutated metastatic prostate cancerDrugs and FDA · 1 outlet
- 13FDA approves mirdametinib for symptomatic, inoperable NF1 tumorsDrugs and FDA · 1 outlet
- 14Houston Rx recalls compounded sermorelin and tirzepatide productsDrug safety · 1 outlet
Evening edition
13 stories
- 1Pelacarsen lowered Lp(a) but did not reduce cardiovascular eventsResearch · 8 outlets
- 2Novartis reports nine tumor cases in children treated with ZolgensmaDrug safety · 4 outlets
- 3PAHO to review U.S. measles elimination status amid rising casesOutbreaks · 4 outlets
- 4ZEUS trial finds ziltivekimab lowered inflammation but not cardiovascular eventsResearch · 5 outlets
- 5FDA approves Rybrevant Faspro for recurrent or metastatic head and neck cancerDrugs and FDA · 3 outlets
- 6Former health adviser accuses White House officials of favoring industryHealth policy · 4 outlets
- 7Health ISAC warns hospitals after cyberattack on French blood servicePublic health · 2 outlets
- 8Doctors warn of small breast cancer risk with menopause hormone therapyDrugs and FDA · 2 outlets
- 9FDA urges DPD deficiency discussions before capecitabine or fluorouracil treatmentDrugs and FDA · 1 outlet
- 10AHA stroke trials report findings on blood pressure and clot preventionResearch · 2 outlets
- 11Hims & Hers will offer Eli Lilly’s branded obesity drugsDrugs and FDA · 2 outlets
- 12Trump administration shifts global health aid to country-by-country agreementsGlobal health · 2 outlets
- 13Houston Rx recalls compounded sermorelin and tirzepatide productsDrug safety · 1 outlet